Evidence map›Paper›PMID 32410933›Full record

ArticleFrontiers in neuroscience2020

Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort.

Florence Esselin, Kevin Mouzat, Anne Polge, Raul Juntas-Morales, Nicolas Pageot, Elisa De la Cruz, Emilien Bernard, Emmeline Lagrange, Véronique Danel, Sébastien Alphandery and 5 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Journal of personalized medicine · 2023
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Florence EsselinCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.
Kevin MouzatLaboratoire de Biochimie et Biologie Moléculaire, CHU Nimes, Univ. Montpellier, Nimes, France.
Anne PolgeLaboratoire de Biochimie et Biologie Moléculaire, CHU Nimes, Univ. Montpellier, Nimes, France.
Raul Juntas-MoralesCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.
Nicolas PageotCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.
Elisa De la CruzCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.
Emilien BernardDépartement de Neurologie, Centre SLA, CHU Wertheimer, Lyon, France.
Emmeline LagrangeEFSN, CHU Grenoble Alpes, Grenoble, France.
Véronique DanelCentre de référence SLA, CHU Salengro, Lille, France.
Sébastien AlphanderyCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.
Laura LabarCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.
Erika NoguéCHU Montpellier, Unité de Recherche Clinique et Epidémiologie (Département Information Médicale), INSERM, Montpellier, France.
Marie-Christine PicotCHU Montpellier, Unité de Recherche Clinique et Epidémiologie (Département Information Médicale), INSERM, Centre d'Investigation Clinique 1411, Univ Montpellier, Montpellier, France.
Serge LumbrosoLaboratoire de Biochimie et Biologie Moléculaire, CHU Nimes, Univ. Montpellier, Nimes, France.
William CamuCentre de référence SLA, CHU Gui de Chauliac, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn familial amyotrophic lateral sclerosis (ALS) cases, the presence of an abnormal C9ORF72 repeat expansion (C9RE) is the most frequent genetic cause identified. Various clinical phenotypes have been described in relation to the presence of C9RE, including psychiatric disorders or Huntington-like symptoms. In a subset of sporadic ALS, C9RE has also been described. In the present study, all index cases with ALS and C9RE identified in our center and their clinical profile, as well as neurological and psychiatric characteristics of identified family members, were described. Clinical characteristics of ALS patients were compared to 999 patients with sporadic ALS (SALS) from our database.

resultsFrom the 70 index cases with ALS identified, a total of 200 individuals were studied, 118 with ALS, 32 with fronto-temporal lobe degeneration (FTD), 37 with ALS/FTD, and 13 with psychiatric disorders. A familial history was present in 57 of the index cases (81%). In ALS and ALS/FTD cases with C9RE, the age of onset (AoO) was earlier than that in SALS cases,

conclusionAlthough our sample size is rather limited, the earlier AoO in index cases and their siblings compared to the parental generation may suggest an anticipation. Reasons for predominance of female transmission are unclear, but the hypothesis that gender influences transmission of the genetic trait or C9RE size variation may be taken into account. Intrafamilial correlation suggests that genetic aspects underlie the occurrence of bulbar onset in ALS patients. Studies on larger samples are warranted to confirm those results.

Indexed as

ALSC9ORF72clinical phenotypecohortfamilial

Identifiers

PMID32410933
PMCPMC7199526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.